经外周静脉输注血管活性药物风险管理范围的综述

doi:10.3761/j.issn.0254-1769.2021.07.025

摘要/Abstract

摘要：

目的探讨经外周静脉输注血管活性药物的风险因素及安全输注方案。方法系统检索5个指南网站、7个中英文数据库,检索时限为建库至2021年3月7日,定性描述经外周静脉输注血管活性药物并发症的基本特征、风险因素及安全输注方案。结果纳入14篇文献,其中指南2篇、系统评价4篇、原始研究8篇。经外周静脉输注血管活性药物的安全性受药物因素、患者因素、输注方案影响。1篇指南和8篇原始研究提供了经外周静脉血管活性药物安全输注方案,内容涉及输注速度、输注部位、输注技术、输注时长、监测频率、并发症处理等。结论实施全程风险评估和安全输注方案,短期经外周静脉输注血管活性药物是安全可行的。

关键词: 血管活性药物, 外周静脉, 并发症, 风险管理, 外渗, 范围综述, 护理

Abstract:

Objective To explore the risk factors and safety infusion protocol of peripheral vasoactive medication. Methods 5 guideline websites and 7 databases were searched from their inception until March 7,2021. We qualitatively described the characteristics of complications,risk factors, and safety infusion protocols of peripheral vasoactive medication. Results A total of 14 articles were incorporated,including 2 guidelines,4 systematic reviews,and 8 original articles. It shows that the safety of peripheral vasoactive medication is affected by drug,patient,and infusion protocol. A guideline and 8 original articles provide the safety infusion protocol,including infusion site,infusion technique,infusion duration,frequency of observation,and management of complications. Conclusion Short-term use of peripheral vasoactive medication is safe and feasible under the whole-process risk assessment and protective strategy.

Key words: Vasoactive Medication, Peripheral Vein, Complication, Risk Management, Extravasation, Scoping Review, Nursing Care

江莹,黎万汇,陈莹莹,仝贝贝,康晓凤,于艳艳,刘亚平. 经外周静脉输注血管活性药物风险管理范围的综述[J]. 中华护理杂志, 2021, 56(7): 1105-1110.

JIANG Ying,LI Wanhui,CHEN Yingying,TONG Beibei,KANG Xiaofeng,YU Yanyan,LIU Yaping. A scoping review on risk management of peripheral vasoactive medication[J]. Chinese Journal of Nursing, 2021, 56(7): 1105-1110.

图/表 4

图1 文献筛选流程图

Figure 1 Flow chart of literature screening

表1 经外周静脉输注血管活性药物原始研究的基本特征

Table 1 Original articles of peripheral vasoactive medication

表2 经外周静脉输注血管活性药物系统评价、指南的基本特征

Table 2 Systematic reviews and guidelines of peripheral vasoactive infusion

表3 经外周静脉血管活性药物安全输注方案

Table 3 Safety infusion protocols of peripheral vasoactive medication

参考文献 26

[1]	Allen JM. Understanding vasoactive medications:focus on pharmacology and effective titration[J]. J Infus Nurs, 2014, 37(2):82-86. DOI URL
[2]	Perlow S, Shapiro RA. Skin necrosis following intravenous use of norepinephrine:report of six cases[J]. Am J Surg, 1956, 92(4):566-570. DOI URL
[3]	Infusion Nurses Society. Infusion nursing standards of practice[EB/OL]. ( 2011)[2021- 03- 17]. http://www.incativ.es/documentos/guias/INS_Standards_of_Practice_2011%5B1%5D.pdf
[4]	Ballard DW, Reed ME, Rauchwerger AS, et al. Emergency phy-sician perspectives on central venous catheterization in the eme-rgency department:a survey-based study[J]. Acad Emerg Med, 2014, 21(6):623-630. DOI PMID
[5]	Loubani OM, Green RS. A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters[J]. J Crit Care, 2015, 30(3):653.e9-17. DOI URL
[6]	WA Country Health Service（WACHS）. Peripheral vasopressor infusion guideline-adults[EB/OL]. ( 2018- 06- 11)[2020- 12- 20]. http://www.wacountry.health.wa.gov.au/fileadmin/sections/policies/Managed/Peripheral_Vasopressor_Infusion_Guideline_Adults_TS-4KSNFPVEZQ_210_9994.pdf
[7]	王喜益, 叶志弘, 汤磊雯. 范围综述在护理领域的应用进展[J]. 中华护理杂志, 2019, 54(8):1259-1263.
	Wang XY, Ye ZH, Tang LW. An integrative review of scoping review applied in nursing literature[J]. Chin J Nurs, 2019, 54(8):1259-1263.
[8]	Arksey H, O’Malley L. Scoping studies:towards a methodological framework[J]. Int J Soc Res Methodol, 2005, 8(1):19-32. DOI URL
[9]	Cardenas-Garcia J, Schaub KF, Belchikov YG, et al. Safety of peripheral intravenous administration of vasoactive medication[J]. J Hosp Med, 2015, 10(9):581-585. DOI PMID
[10]	Nguyen TT, Surrey A, Barmaan B, et al. Utilization and extravasation of peripheral norepinephrine in the emergency department[J]. Am J Emerg Med, 2021, 39:55-59. DOI URL
[11]	龚玲, 陈璐, 朱爱娟. 品管圈在降低外周静脉输注血管活性药物安全隐患率中的应用[J]. 当代护士(上旬刊), 2020, 27(1):167-170.
	Gong L, Chen L, Zhu AJ. Application of quality control circle in reducing the potential safety rate of peripheral vasoactive medication[J]. Today Nurse, 2020, 27(1):167-170.
[12]	Pancaro C, Shah N, Pasma W, et al. Risk of major complications after perioperative norepinephrine infusion through peri-pheral intravenous lines in a multicenter study[J]. Anesth Analg, 2020, 131(4):1060-1065. DOI PMID
[13]	曾慧兰, 彭杏, 鲁静琦, 等. 针对性护理干预对外周静脉血管活性药物所致的静脉炎及患者生活质量的影响[J]. 当代护士, 2019, 26(12):145-147.
	Zeng HL, Peng X, Lu JQ, et al. The effect of targeted nursing intervention on phlebitis caused by peripheral vasoactive medication and the quality of life of patients[J]. Today Nurse, 2019, 26(12):145-147.
[14]	Ballieu P, Besharatian Y, Ansari S. Safety and feasibility of phe-nylephrine administration through a peripheral intravenous catheter in a neurocritical care unit[J]. J Intensive Care Med, 2021, 36(1):101-106. DOI URL
[15]	Lewis T, Merchan C, Altshuler D, et al. Safety of the peripheral administration of vasopressor agents[J]. J Intensive Care Med, 2019, 34(1):26-33. DOI URL
[16]	Delgado T, Wolfe B, Davis G, et al. Safety of peripheral administration of phenylephrine in a neurologic intensive care unit:a pilot study[J]. J Crit Care, 2016, 34:107-110. DOI PMID
[17]	Djogovic D, MacDonald S, Wensel A, et al. Vasopressor and inotrope use in Canadian emergency departments:evidence based consensus guidelines[J]. CJEM, 2015, 17(Suppl 1):1-16. DOI URL
[18]	Nickel B. Peripheral intravenous administration of high-risk infusions in critical care:a risk-benefit analysis[J]. Crit Care Nurse, 2019, 39(6):16-28. DOI PMID
[19]	Tian DH, Smyth C, Keijzers G, et al. Safety of peripheral administration of vasopressor medications:a systematic review[J]. Emerg Med Australas, 2020, 32(2):220-227. DOI URL
[20]	Tran QK, Mester G, Bzhilyanskaya V, et al. Complication of vasopressor infusion through peripheral venous catheter:a systematic review and meta-analysis[J]. Am J Emerg Med, 2020, 38(11):2434-2443. DOI URL
[21]	吴琴珍, 潘月敏, 石红荣, 等. 静脉用药安全管理中的前馈控制[J]. 中华护理杂志, 2014, 49(7):824-827.
	Wu QZ, Pan YM, Shi HR, et al. Application of feedforward control to the safety management of intravenous medicine administration[J]. Chin J Nurs, 2014, 49(7):824-827.
[22]	姜贺, 许乐. 4R危机管理理论在护理风险管理中的应用[J]. 中国护理管理, 2011, 11(5):57-59.
	Jiang H, Xu L. The application of 4R-model crisis management theory in nursing risk management[J]. Chin Nurs Manag, 2011, 11(5):57-59.
[23]	Padrone L, Galiczewski J, Amitrano B, et al. The development of a nurse-driven protocol for the safe administration of vasopressors through peripheral intravenous catheters[J]. Int J Heal-thc, 2018, 4(1):36.
[24]	Parry A. How to administer inotropic drugs[J]. Nurs Stand Royal Coll Nurs G B, 2015, 30(4):36-39.
[25]	夏冬云, 史婷奇, 陆巍, 等. 压力性损伤临床决策支持系统的研发与应用[J]. 中华护理杂志, 2020, 55(1):50-54.
	Xia DY, Shi TQ, Lu W, et al. Development and application of clinical decision support system for pressure injury[J]. Chin J Nurs, 2020, 55(1):50-54.
[26]	刘改红, 李红梅, 李娇. ICU护理人员对血管活性药物相关知识认知现状及干预对策[J]. 齐鲁护理杂志, 2017, 23(3):42-43.
	Liu GH, Li HM, Li J. Investigation and intervention of peripheral vasoactive medication knowledge in ICU[J]. J Qilu Nurs, 2017, 23(3):42-43.